Form 8-K - Current report:
SEC Accession No. 0001193125-19-308250
Filing Date
2019-12-06
Accepted
2019-12-06 16:02:06
Documents
3
Period of Report
2019-12-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d831463d8k.htm 8-K 19411
2 EX-1.1 d831463dex11.htm EX-1.1 234377
3 EX-5.1 d831463dex51.htm EX-5.1 4759
  Complete submission text file 0001193125-19-308250.txt   259983
Mailing Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101
Business Address 225 SOUTH LAKE AVENUE SUITE 1050 PASADENA CA 91101 626-304-3400
ARROWHEAD PHARMACEUTICALS, INC. (Filer) CIK: 0000879407 (see all company filings)

EIN.: 460408024 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-38042 | Film No.: 191273107
SIC: 2834 Pharmaceutical Preparations